Research and surveillance activities include surveillance of vaccine preventable diseases, vaccination coverage and adverse events, vaccine safety and program evaluations and social research. NCIRS also provides technical support for the Australian Technical Advisory Group on Immunisation, including production of The Australian Immunisation Handbook.
Vaccine Safety Net Member
Our website meets the criteria for credibility and content as defined by the Global Advisory Committee on Vaccine Safety.
We acknowledge that the National Centre for Immunisation Research & Surveillance (NCIRS) is on the land of the traditional owners the Aboriginal and Torres Strait Islander peoples, the First Australians, and recognise their culture, history, diversity and their deep connection to the land. Together, through research and partnership, we aim to move to a place of equity for all. NCIRS also acknowledges and pays respect to other Aboriginal and Torres Strait Islander nations from which our research, staff and community are drawn.
* ‘Indigenous’ is used on these pages to incorporate all Aboriginal and Torres Strait Islander peoples.
Innovative new AusVaxSafety data confirms the 2017 influenza vaccines to be safe. No vaccine safety concerns were identified in approximately 74,000 adults and children vaccinated since April this year.
NPS MedicineWise has partnered with the National Centre for Immunisation Research and Surveillance (NCIRS) to deliver a landmark, nationally coordinated immunisation support program for Primary Health Networks (PHNs) across Australia.
The program, entitled the Primary Health Networks Immunisation Support Program, will be co-designed with PHNs to better support and coordinate immunisation providers and services in their regions. The aim is to ensure PHN efforts across the country deliver on National Immunisation Program goals and are as consistent as possible, while addressing specific challenges in their local areas.